SE8204058L - Cancercellangripande lymfocyter, forfarande for framstellning derav och anticancermedel innehallande nemnda lymfocyter - Google Patents

Cancercellangripande lymfocyter, forfarande for framstellning derav och anticancermedel innehallande nemnda lymfocyter

Info

Publication number
SE8204058L
SE8204058L SE8204058A SE8204058A SE8204058L SE 8204058 L SE8204058 L SE 8204058L SE 8204058 A SE8204058 A SE 8204058A SE 8204058 A SE8204058 A SE 8204058A SE 8204058 L SE8204058 L SE 8204058L
Authority
SE
Sweden
Prior art keywords
lymphocytes
cancer cell
angly
procedures
producing
Prior art date
Application number
SE8204058A
Other languages
English (en)
Swedish (sv)
Other versions
SE8204058D0 (sv
Inventor
M Adachi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15641481A external-priority patent/JPS5857321A/ja
Priority claimed from JP56156413A external-priority patent/JPS5857318A/ja
Priority claimed from JP56158473A external-priority patent/JPS5859923A/ja
Priority claimed from JP56158472A external-priority patent/JPS5859922A/ja
Priority claimed from JP57111168A external-priority patent/JPS591420A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8204058D0 publication Critical patent/SE8204058D0/xx
Publication of SE8204058L publication Critical patent/SE8204058L/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5158Antigen-pulsed cells, e.g. T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
SE8204058A 1981-10-01 1982-06-30 Cancercellangripande lymfocyter, forfarande for framstellning derav och anticancermedel innehallande nemnda lymfocyter SE8204058L (sv)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP15641481A JPS5857321A (ja) 1981-10-01 1981-10-01 抗癌剤
JP56156413A JPS5857318A (ja) 1981-10-01 1981-10-01 癌細胞障害性リンパ球の製造法
JP56158473A JPS5859923A (ja) 1981-10-05 1981-10-05 抗癌剤
JP56158472A JPS5859922A (ja) 1981-10-05 1981-10-05 癌細胞障害性リンパ球
JP57111168A JPS591420A (ja) 1982-06-28 1982-06-28 糖鎖関連抗原およびその製造法

Publications (2)

Publication Number Publication Date
SE8204058D0 SE8204058D0 (sv) 1982-06-30
SE8204058L true SE8204058L (sv) 1983-04-02

Family

ID=27526479

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204058A SE8204058L (sv) 1981-10-01 1982-06-30 Cancercellangripande lymfocyter, forfarande for framstellning derav och anticancermedel innehallande nemnda lymfocyter

Country Status (19)

Country Link
AR (1) AR230731A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (2) AT382080B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU554858B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE893704A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1195269A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH655661B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (2) DD221917A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE3236298A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK292182A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI77157C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2513882B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL66270A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1189305B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX7437E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8202638A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO161601C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ201112A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT75148B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE8204058L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
EP0334300A1 (en) * 1988-03-21 1989-09-27 Neorx Corporation The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
DE1943699A1 (de) * 1969-08-28 1971-03-04 Stiftung Onophrio Heilmittel mit proliferationshemmender Wirkung und Verfahren zur Herstellung dieses Heilmittels
YU34005B (en) * 1970-02-24 1978-10-31 Podvinec Srecko Process for obtaining bovine lymphatic gland extract
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate

Also Published As

Publication number Publication date
AU8545882A (en) 1983-04-14
BE893704A (fr) 1982-10-18
AU554858B2 (en) 1986-09-04
FI77157B (fi) 1988-10-31
DE3249568C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-10-01
FR2513882B1 (fr) 1986-04-04
DE3249568A1 (de) 1985-02-07
DD209577A5 (de) 1984-05-16
IL66270A0 (en) 1982-11-30
DE3236298C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-09-24
NO161601C (no) 1989-09-06
PT75148B (en) 1986-08-14
NZ201112A (en) 1986-10-08
ATA363782A (de) 1986-06-15
FR2513882A1 (fr) 1983-04-08
IT1189305B (it) 1988-02-04
NL8202638A (nl) 1983-05-02
FI77157C (fi) 1989-02-10
NO822215L (no) 1983-04-05
NO161601B (no) 1989-05-29
DD221917A5 (de) 1985-05-08
AR230731A1 (es) 1984-06-29
MX7437E (es) 1988-11-14
SE8204058D0 (sv) 1982-06-30
IL66270A (en) 1986-03-31
CA1195269A (en) 1985-10-15
CH655661B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-05-15
IT8248724A0 (it) 1982-06-30
CH655660B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-05-15
AT390002B (de) 1990-03-12
PT75148A (en) 1982-07-01
FI822325A0 (fi) 1982-06-29
ATA354585A (de) 1989-08-15
DK292182A (da) 1983-04-02
AT382080B (de) 1987-01-12
DE3236298A1 (de) 1984-03-15
FI822325L (fi) 1983-04-02

Similar Documents

Publication Publication Date Title
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
NL990027I1 (nl) Bisindoolverbindingen, farmaceutische preparaten die hen bevatten en werkwijze voor hun bereiding.
UA13038A1 (uk) Спосіб одержаhhя таблеток
NL960028I1 (nl) ML-236B-derivaten, werkwijze voor hun bereiding enfarmaceutische preparaten, die deze derivaten bev atten.
IT8220140A0 (it) Procedimento per la produzione di sostanze prodotte da cellule, particolarmente di anticorpi esimili.
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
IT1167610B (it) Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione
NL190552C (nl) 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL193164B (nl) Farmaceutisch tablet voor gecontroleerde, langdurige afgifte van een actieve verbinding.
NL8103768A (nl) Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL190844B (nl) Sulfoniumverbindingen, werkwijzen voor de bereiding van deze verbindingen en farmaceutische preparaten, die deze verbindingen bevatten.
NL169488C (nl) Werkwijze voor de bereiding van vormmassa's van thermoplastische macromoleculaire aromatische polycarbonaten die een losmiddel bevatten, alsmede gevormde voortbrengselen geheel of ten dele vervaardigd uit de verkregen vormmassa.
NL930078I2 (nl) Aminederivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten die deze bevatten.
NL8601837A (nl) Poly-4-aminopyrrool-2-carboxamidoderivaten, werkwijze ter bereiding ervan, farmaceutische preparaten, die deze derivaten bevatten alsmede werkwijze voor de bereiding van de farmaceutische preparaten.
AU3765072A (en) Implant for direct infusion of biologically active substances, a method for producing same anda mould for carrying out the method
IT1164106B (it) Procedimento per la produzione di 14,15-derivati metilenici della serie d'estrano
IT1209896B (it) Antibiotico bmg162-af2 procedimento per la sua produzione e medicinale antitumorale contenente il suddetto antibiotico come ingrediente attivo
AU7415181A (en) Polymeric diffusion matrix for administration of drugs
NL7901251A (nl) Werkwijze voor het bereiden van een optisch actief ben- zamide, het op deze wijze verkregen optisch actieve benzamide en farmaceutische preparaten die deze ver- binding bevatten.
SE8204058L (sv) Cancercellangripande lymfocyter, forfarande for framstellning derav och anticancermedel innehallande nemnda lymfocyter
NL7703753A (nl) Werkwijze ter bereiding van een antitumorigeen antibioticum, en gevormd geneesmiddel, evenals werkwijze ter bereiding van de actieve verbin- ding.
NL7413788A (nl) Werkwijze voor de bereiding van biologisch actieve benzoxazolen, werkwijze voor de be- reiding van een gevormd geneesmiddel en een dergelijk geneesmiddel.
IT8321732A0 (it) Apparecchio di diluizione, specialmente per la fabbricazione di medicinali omeopatici.
ES452174A1 (es) Procedimiento de preparacion de 2,9-dioxatriciclo (4,3,1, 03,7) decanos.
FI811662A7 (fi) Tinayhdisteitä, menetelmä niiden valmistamiseksi, menetelmä syöpälääkkeiden valmistamiseksi näistä tinatinayhdisteistä sekä näin saadut lääkevalmisteet.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8204058-5

Effective date: 19910927

Format of ref document f/p: F